The effects of rAAV2-mediated NGF gene delivery in adult and aged rats.
Nerve growth factor (NGF) therapy has been proposed to treat patients with age-related cognitive deficits, including those with Alzheimer's disease. One promising approach to delivering this protein into brain involves viral vectors. However, little is known about the effects of aging on gene transfer in brain generally and in particular its effect on transgenic NGF expression. To examine the transgene expression and biological effects of NGF gene transfer in adult and aged rats, we delivered mouse NGF with C-terminal myc-tag, using a recombinant adeno-associated virus serotype 2 (rAAV2) vector, into the septum of 6- and 21-month-old Fischer 344/Brown Norway hybrid rats. Other animals received a control vector encoding green fluorescent protein. As expected, this strain of rat demonstrated very few age-related deficits in spatial memory-related behavior in the Morris water task either before gene transfer (6 vs 21 months) or afterward (up to 11 vs 26 months). We found that rAAV2 vectors drove transgene expression in aged rats up to 5 months, although the level of transgene expression was lower than that of adult animals. We also showed that NGF gene transfer into the septum of aged animals induced local trophic effects by increasing the number and soma area of septal cholinergic neurons and improved distal synaptic activity by increasing the level of depolarization-induced acetylcholine (ACh) release from hippocampal synaptic terminals. Interestingly, NGF gene transfer suppressed depolarization-induced ACh release in adult rats. These findings show for the first time, to our knowledge, that septal NGF gene transfer modulates hippocampal nerve terminal function. These results are relevant for the potential clinical application of NGF gene therapy.
Wu
Ke
K
Department of Pharmacology, University of Florida, Gainesville, FL 32610, USA. kewu@ufl.edu
Meyers
Craig A
CA
Guerra
Nicole K
NK
King
Michael A
MA
Meyer
Edwin M
EM
D000109:Acetylcholine / Q000378:metabolism; D000375:Aging / Q000502:physiology*; D000818:Animals; D002799:Cholinergic Fibers / Q000378:metabolism; D000229:Dependovirus / Q000235:genetics* / Q000502:physiology; D015316:Genetic Therapy; D005822:Genetic Vectors / Q000235:genetics; D018782:Maze Learning; D008569:Memory Disorders / Q000235:genetics / Q000628:therapy; D020932:Nerve Growth Factor / Q000235:genetics* / Q000378:metabolism* / Q000627:therapeutic use; D009474:Neurons / Q000378:metabolism; D051381:Rats; D011914:Rats, Inbred BN; D011916:Rats, Inbred F344; D019076:Transgenes / Q000235:genetics
D020932:Nerve Growth Factor; D000109:Acetylcholine